Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Diabetes Care

• Publication date

  2017-10-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc17-1467PMID 29079715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

  2017cited by this paper
• Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

  2016cited by this paper
• Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

  2016cited by this paper
• Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.

  2015cited by this paper
• Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.

  2015cited by this paper
• Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.

  2015cited by this paper
• Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View

  2015cited by this paper
• Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

  2014cited by this paper
• Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.

  2014cited by this paper
• Diabetic Kidney Disease: A Report From an ADA Consensus Conference

  2014cited by this paper
• Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria).

  2013cited by this paper
• Within-person variability in kidney measures.

  2013cited by this paper
• Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.

  2012cited by this paper
• Changes in albuminuria predict mortality and morbidity in patients with vascular disease.

  2011cited by this paper
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

  2010cited by this paper
• Intensive blood-pressure control in hypertensive chronic kidney disease.

  2010cited by this paper
• Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

  2008cited by this paper
• The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis

  2008influential reference
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.

  2005cited by this paper
• The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

  2005cited by this paper
• The number, quality, and coverage of randomized controlled trials in nephrology.

  2004cited by this paper
• Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

  2004cited by this paper
• Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease.

  2004cited by this paper
• Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy

  2003cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease – preterax and diamicron MR controlled evaluation

  2001cited by this paper
• Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation

  2001cited by this paper
• The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.

  1997cited by this paper
• Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

  1990cited by this paper
• Albuminuria reflects widespread vascular damage

  1989cited by this paper
• DEATHS from diabetes.

  1952cited by this paper

• Changes in urine albumin-to-creatinine ratio and health care resource utilization and costs in patients with type 2 diabetes and chronic kidney disease.

  2025cites this paper
• Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update

  2025cites this paper
• Surrogate endpoints in diabetic kidney disease: current perspectives and future directions

  2025cites this paper
• Evaluation of renal and inflammatory markers in elderly diabetic patients in Port Harcourt

  2025cites this paper
• Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

  2025cites this paper
• Verification of the Impact of Changes in the Severity Classification of Proteinuria on the Prognosis of Hypertensive Patients Following the Initiation of Esaxerenone

  2024cites this paper
• Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature

  2024cites this paper
• Adherence to diabetes quality indicators in primary care and all-cause mortality: A nationwide population-based historical cohort study

  2024cites this paper
• Association of proteinuria and risk of incident atrial fibrillation in the general population: A prospective study of Kailuan study participants

  2023cites this paper
• Albuminuria and Heart Failure: JACC State-of-the-Art Review.

  2023cites this paper
• Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance

  2023cites this paper
• From normal population to prediabetes and diabetes: study of influencing factors and prediction models

  2023cites this paper
• Prognostic significance of albuminuria in elderly of various ages with diabetes

  2023cites this paper
• Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD

  2023cites this paper
• Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review

  2023cites this paper
• Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes

  2023cites this paper
• Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes

  2023influential citation
• Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort

  2022cites this paper
• Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients

  2022cites this paper
• Elevated albumin-to-creatinine ratio as a risk factor for stroke and homocysteine as an effect modifier in hypertensive Asian individuals

  2021cites this paper
• Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

  2021cites this paper
• Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects

  2021cites this paper
• Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B

  2021cites this paper
• Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.

  2021cites this paper
• Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry

  2021cites this paper
• WITHDRAWN: The Potential of Spot and Overnight Urine in the Evaluating of Proteinuria and Electrolyte

  2021cites this paper
• La dysfonction endothéliale : signification clinique et implications thérapeutiques

  2021cites this paper
• Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort

  2021cites this paper
• The potential of spot and overnight urine in the evaluating of proteinuria and electrolyte

  2021cites this paper
• 1 METS-IR , a novel score to evaluate insulin sensitivity , is associated with the 1 urinary albumin – creatinine ratio in Chinese adults : A cross-sectional 2 REACTION study 3

  2021cites this paper
• Beneficial Effects of Physical Activity in Diabetic Patients

  2020cites this paper
• The new biology of diabetic kidney disease - mechanisms and therapeutic implications.

  2020cites this paper
• Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease

  2020cites this paper
• ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE

  2020cites this paper
• Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study

  2020cites this paper
• Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial.

  2020cites this paper
• Management of proteinuria: blockade of the renin–angiotensin–aldosterone system

  2020cites this paper
• Immunosuppression for COVID-19: repurposing medicines in a pandemic

  2020cites this paper
• Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

  2020cites this paper
• Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial

  2020cites this paper
• Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism

  2020cites this paper
• Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes

  2020cites this paper
• Kynurenine/Tryptophan Ratio Predicts Angiotensin Receptor Blocker Responsiveness in Patients with Diabetic Kidney Disease

  2020cites this paper
• Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

  2019cites this paper
• Change in Proteinuria or Albuminuria as a Surrogate for Cardiovascular and Other Major Clinical Outcomes: A Systematic Review and Meta-analysis.

  2019cites this paper
• Proteinuria as a Potential Biomarker for the Efficacy of Intravitreal Bevacizumab Injection in Patients with Diabetic Macular Edema

  2019cites this paper
• Observational analyses from ADVANCE and ADVANCE‐ON

  2019cites this paper
• Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

  2019cites this paper
• STORIA NATURALE DELLA MALATTIA RENALE NEL DIABETE E TRATTAMENTO DELL’IPERGLICEMIA NEI PAZIENTI CON DIABETE DI TIPO 2 E RIDOTTA FUNZIONE RENALE

  2019cites this paper
• Dipstick analysis of urine chemistry: benefits and limitations of dry chemistry-based assays

  2019cites this paper
• A Combination of Change in Albuminuria and GFR as a Surrogate End Point for Progression of CKD.

  2019cites this paper
• Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account

  2018cites this paper
• Comprehensive risk management of diabetic kidney disease in patients with type 2 diabetes mellitus

  2018cites this paper